Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1984 5
1985 4
1986 12
1987 18
1988 24
1989 25
1990 20
1991 17
1992 20
1993 11
1994 19
1995 16
1996 19
1997 16
1998 12
1999 9
2000 6
2001 12
2002 10
2003 7
2004 7
2005 3
2006 3
2007 5
2008 6
2009 2
2010 2
2011 3
2012 6
2013 7
2014 5
2015 7
2016 4
2017 2
2018 3
2019 3
2020 3
2021 3
2022 4
2023 3
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for moab d
Search for Moabi D instead (3 results)
Higher affinity human D MoAb prepared by light-chain shuffling and selected by phage display.
Proulx C, Boyer L, St-Amour I, Bazin R, Lemieux R. Proulx C, et al. Transfusion. 2002 Jan;42(1):59-65. doi: 10.1046/j.1537-2995.2002.00006.x. Transfusion. 2002. PMID: 11896314
BACKGROUND: In blood banks, D MoAbs are routinely used to phenotype donors and patients. However, most D MoAbs do not agglutinate RBCs that weakly express D. ...RESULTS: L-chain shuffling combined with phage display permitted the selection of a 43F10 MoAb …
BACKGROUND: In blood banks, D MoAbs are routinely used to phenotype donors and patients. However, most D MoAbs do not agglutin …
Serologic strategy in detecting RHD altered alleles in Brazilian blood donors.
Person RDM, Arnoni CP, Muniz JG, Vendrame TAP, Latini FRM, Cortez AJP, Pellegrino J Jr, Castilho LM. Person RDM, et al. Hematol Transfus Cell Ther. 2020 Oct-Dec;42(4):365-372. doi: 10.1016/j.htct.2019.08.004. Epub 2019 Oct 13. Hematol Transfus Cell Ther. 2020. PMID: 31780389 Free PMC article. Review.
The monoclonal-monoclonal blend RUM-1/MS26 was the best anti-D reagent used in detecting the D antigen in the IS phase in a tube, reacting with 83.2% of the D variants, while the anti-D blend D175 + 415 was the best monoclonal antibody (MoAb) us …
The monoclonal-monoclonal blend RUM-1/MS26 was the best anti-D reagent used in detecting the D antigen in the IS phase in a tu …
99mTc anti-D-dimer MoAb detects venous thrombi in man.
Merlino G, Soluri A, La Torre F, Ciavolella M, Schillaci O, Ierardi M, De Vincentis G, Tavolaro R, De Paola A, Sardelli E, Scopinaro F. Merlino G, et al. G Chir. 1997 Oct;18(10):653-4. G Chir. 1997. PMID: 9435144
Authors' work is based on the ability of a 99mTc labelled antibody (MoAb) against D-Dimer (D-D) to visualize thrombi in man. D-Dimer is a specific epitope created during the cross-linking process of fibrin strains. ...In non operated patients th …
Authors' work is based on the ability of a 99mTc labelled antibody (MoAb) against D-Dimer (D-D) to visualize thr …
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype.
Lai M, Grasso C, Boschi I, D'Onofrio G, Pascali V, Leone G. Lai M, et al. Transfusion. 2009 May;49(5):937-42. doi: 10.1111/j.1537-2995.2008.02066.x. Epub 2009 Jan 21. Transfusion. 2009. PMID: 19175552
BACKGROUND: Anti-D monoclonal antibody (MoAb) reagents have improved D typing in routine tests. However, they exhibit a wide range of reactivity with the weak D phenotype depending on the characteristics of the different MoAbs used. We analyzed the rea …
BACKGROUND: Anti-D monoclonal antibody (MoAb) reagents have improved D typing in routine tests. However, they exhibit a …
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.
Cho SF, Xing L, Anderson KC, Tai YT. Cho SF, et al. Cancers (Basel). 2021 Dec 6;13(23):6136. doi: 10.3390/cancers13236136. Cancers (Basel). 2021. PMID: 34885245 Free PMC article. Review.
These MoAb-based agents significantly induce cytotoxicity of MM cells via multiple effector-dependent mechanisms and can further induce immunomodulation to repair a dysfunctional tumor immune microenvironment. ...New antigens, such as orphan G protein-coupled receptor clas …
These MoAb-based agents significantly induce cytotoxicity of MM cells via multiple effector-dependent mechanisms and can further indu …
Measurement of anti-D intrinsic affinity with unlabeled antibodies.
Debbia M, Lambin P. Debbia M, et al. Transfusion. 2004 Mar;44(3):399-406. doi: 10.1111/j.1537-2995.2004.00651.x. Transfusion. 2004. PMID: 14996198
BACKGROUND: The method most commonly used for measuring the affinity of MoAbs specific for the D antigen is a binding assay using 125I-labeled MoAb. Although the method is relatively simple, there are several drawbacks that can lead to inaccurate results. The object …
BACKGROUND: The method most commonly used for measuring the affinity of MoAbs specific for the D antigen is a binding assay using 125 …
Elevated perioptic lipocalin-type prostaglandin D synthase concentration in patients with idiopathic intracranial hypertension.
Pircher A, Montali M, Berberat J, Huber A, Miller NR, Mader TH, Gibson CR, Neutzner A, Remonda L, Killer HE. Pircher A, et al. Brain Commun. 2022 Sep 26;4(5):fcac240. doi: 10.1093/braincomms/fcac240. eCollection 2022. Brain Commun. 2022. PMID: 36262370 Free PMC article.
CSF was analysed for lipocalin-type prostaglandin D synthase and the concentrations compared between the two sites using nephelometry. The mean lipocalin-type prostaglandin D synthase concentration in the perioptic subarachnoid space was significantly higher compare …
CSF was analysed for lipocalin-type prostaglandin D synthase and the concentrations compared between the two sites using nephelometry …
Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
Credidio DC, Pellegrino J, Castilho L. Credidio DC, et al. Immunohematology. 2011;27(1):6-11. Immunohematology. 2011. PMID: 22356480
Rh discrepancies are a problem during routine testing because of partial D or weak D phenotypes. Panels of monoclonal antibodies (MoAb) are being developed to identify D variants such as partial D and weak D when there are anomalous D …
Rh discrepancies are a problem during routine testing because of partial D or weak D phenotypes. Panels of monoclonal antibodi …
A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
Yu X, Menard M, Seabright G, Crispin M, Lazarus AH. Yu X, et al. Transfusion. 2015 Jun;55(6 Pt 2):1501-11. doi: 10.1111/trf.13032. Epub 2015 Mar 6. Transfusion. 2015. PMID: 25752470
BACKGROUND: The mechanism of action of anti-D in ameliorating immune thrombocytopenia (ITP) remains unclear. The monoclonal antibody (MoAb) Ter119, which targets murine red blood cells (RBCs), has been shown to mimic the effect of anti-D in improving antibody …
BACKGROUND: The mechanism of action of anti-D in ameliorating immune thrombocytopenia (ITP) remains unclear. The monoclonal antibody …
A conserved interdomain microbial network underpins cadaver decomposition despite environmental variables.
Burcham ZM, Belk AD, McGivern BB, Bouslimani A, Ghadermazi P, Martino C, Shenhav L, Zhang AR, Shi P, Emmons A, Deel HL, Xu ZZ, Nieciecki V, Zhu Q, Shaffer M, Panitchpakdi M, Weldon KC, Cantrell K, Ben-Hur A, Reed SC, Humphry GC, Ackermann G, McDonald D, Chan SHJ, Connor M, Boyd D, Smith J, Watson JMS, Vidoli G, Steadman D, Lynne AM, Bucheli S, Dorrestein PC, Wrighton KC, Carter DO, Knight R, Metcalf JL. Burcham ZM, et al. Nat Microbiol. 2024 Mar;9(3):595-613. doi: 10.1038/s41564-023-01580-y. Epub 2024 Feb 12. Nat Microbiol. 2024. PMID: 38347104 Free PMC article.
361 results